It is also overexpressed in non-small-cell lung cancer (NSCLC) and induces cell growth and survival through the transcriptional activation of vascular endothelial growth factor (VEGF) that activates various signaling pathways including mitogen-activated protein kinase (MAPK) and PI3K [87]. This evidence concerns the gene WNK2 and non-small cell lung carcinoma.